Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (4): 423-426.

Previous Articles     Next Articles

Control study of Sulpiride and Olanzapine in the treatment of anorexia nervosa

ZHONG Zhi-yong1,2,WU Xiao-li1 ,CHEN Min-feng1,ZHANG Jin-bei1   

  1. 1Department of Psychiatry, the Third Affiliated Hospital of Sun Yet-sen University,Guangzhou 510630,Guangdong,China;
    2Mental Health Center, the Second Xiangya Hospital of Central South University,Changsha 410011,Hunan,China
  • Received:2011-04-11 Revised:2011-04-24 Published:2011-06-22

Abstract: AIM: To compare the difference of effect and side effects of Sulpiride with Paroxetine and Olanzapine with Paroxetine in the treatment of anorexia nervosa. METHODS: 57 anorexia vervosa patients were involved in the research, including 25 cases of Sulpiride group,32 cases of Olanzapine group, before and after the treatment, body weight, body mass index (BMI), Hamilton anxiety scale (HAMA), Hamilton depression rating scale (HAMD) and Treatment emergent side-effect scale (TESS) were used to evaluate the curative effect and the adverse drug reactions. RESULTS: After 8 weeks treatment ,the indexes of body weight, BMI, HAMA,HAMD were obviously better than those of before treatment (P<0.05). The indexes of body weight and BMI of Olanzapine group were better than those in Sulpiride group after 8 weeks treatment (P<0.05), but there were no difference of HAMA,HAMD and TESS between two groups(P>0.05) . CONCLUSION: After analysis of the indexes as body weight, BMI, HAMA, HAMD and TESS, the following conclusions are made: the two methods are both effective to the treatment of anorexia noversa, but the Olanzapine with Paroxetine is better than Sulpiride with Paroxetine in improving the body weight and the BMI. The difference of the adverse drug reactions is not found in the two groups.

Key words: Anorexia nervosa, Sulpiride, Olanzapine, Body mass index(BMI)

CLC Number: